Quality by Design (QbD)-Driven Development and Optimization of Tacrolimus-Loaded Microemulsion for the Treatment of Skin Inflammation
2024

Developing a New Microemulsion for Tacrolimus to Treat Skin Inflammation

publication 10 minutes Evidence: high

Author Information

Author(s): Srishti Sanjida Ahmed, Pinky Paromita Paul, Taylor Ryan, Guess Jacob, Karlik Natasha, Janjic Jelena M., Savic Snezana, Savic Sanela, Ilić Tanja

Primary Institution: Duquesne University, Pittsburgh, PA, USA

Hypothesis

Can a Quality by Design (QbD) approach optimize the development of a tacrolimus-loaded microemulsion for effective skin inflammation treatment?

Conclusion

The study successfully developed a stable tacrolimus-loaded microemulsion that enhances drug delivery for treating skin inflammation.

Supporting Evidence

  • The microemulsion showed a slow and extended drug release profile in vitro.
  • More than 50% tacrolimus loading was achieved in the microemulsion.
  • The QbD approach allowed for the identification of critical parameters for manufacturing.
  • The selected microemulsion candidate met all critical quality attributes (CQAs).
  • The study demonstrated successful scale-up of the microemulsion formulation.
  • Statistical analysis indicated significant effects of processing pressure on particle size.
  • The microemulsion formulation maintained stability over time in serum studies.
  • The findings suggest a promising method for localized delivery of tacrolimus.

Takeaway

Researchers created a special lotion that helps a medicine called tacrolimus work better on skin problems. This lotion is made using a smart method to make sure it works well.

Methodology

The study used a Quality by Design (QbD) approach, including risk assessment and design of experiments (DoE), to optimize the formulation and manufacturing process of the microemulsion.

Potential Biases

Potential biases may arise from the selection of formulation parameters and the specific conditions under which the experiments were conducted.

Limitations

The study primarily focused on in vitro results, and further clinical trials are needed to confirm efficacy in patients.

Statistical Information

P-Value

p<0.00005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/pharmaceutics16121487

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication